Know How and Passion
Our management team at AOP Health is composed of highly skilled experts whose careers and educational background are mostly in the natural sciences. They are a strong representation of the competence and professionalism that is found in each of our employees.
Know How and Passion
Dr. Günther Krumpl, board member, AOP Health Group, medical doctor, pharmacologist, Associate Professor and entrepreneurial pioneer in the pharmaceutical industry,
Dr. Rudolf Widmann, board member, AOP Health Group, founder of the company, pharmacist by education with deep knowledge and passion for rare diseases treatments and research,
Mag. Andreas Steiner, Group CEO, AOP Health Group, an economist by education brings both inside views from the pharmaceutical industry as well as hospital management,
Dr. Martin Steinhart, CEO, AOP Orphan Pharmaceuticals GmbH, medical doctor by education, brings expertise in research and development as well as strategic know-how of international medical affairs and developing new markets.
Bernhard Nachbaur, LL.M., CEO, AOP Orphan Pharmaceuticals GmbH, a tax-law expert, brings longstanding experience in entrepreneurship and financial management within the pharmaceutical industry as well as strategic expertise in business development.
The management consists of a team of highly qualified professionals, most of whom have a degree in natural sciences and have extensive research experience both at universities and in industry research institutions. What unites them all, however, is not their common scientific background, but rather their passion for innovative therapies for rare diseases and critical care.
It is this passion that drives our management team and all our employees to be fully dedicated to developing and manufacturing efficient medicines that effectively treat diseases and improve patients' quality of life as much as possible.
Strategic Management
"AOP Health having international expertise in pharmaceutical and clinical development as well as distribution and marketing offers flexible solutions for in- and out-licensing partnerships."
"As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care."
"AOP Health is unconditionally committed to bringing not only drugs but full treatment support to patients with rare diseases and in critical care."
Chief Executive Officers
"At AOP Health, we strive to develop and market innovative and effective therapies for patients with rare diseases and in critical care. This is our daily motivation to provide sustainable support to those who need it most - the patients!"
"The needs of our patients are at the center of everything we do. We therefore combine our passion and commitment in all areas of the company to be able to offer integrated therapy solutions to those affected."
Corporate Executive Committee
"Every day we at AOP Health consolidate our knowledge, expertise and energy to ensure that the patients get necessary treatments available notwithstanding the market complexity and challenges."
"AOP Health is an agile company operating worldwide via own local enterprises and partnerships. Each country has its own regulations that apply to drug research and development, manufacturing, marketing and post marketing activities - to name a few. At AOP Health we do our best to keep up the high standards at every step for the health and safety of the patients!"
"In the highly specific field of rare diseases, it is particularly important to develop not only innovative but above all effective drugs and reliable treatments. We have the highest quality standards, as we know that our products are vital for patients. Quality begins by placing customer satisfaction at the center of our thinking."
"At AOP Health, we are committed to fostering an environment in which our associates can unfold their full potential and are recognized for their contributions"
Scientific and Medical Officers
"AOP Health has successfully developed a number of innovative treatment options in recent years. To arrive at these, our thinking is guided above all by patient needs."
"To provide patients with effective drugs COLLABORATION is the key for success- within and between pharmaceutical industry and academia."